USE OF A TECHNICALLY MODIFIED CELL AS A VACCINE FOR TREATING TUMORAL DISEASE

Details for Australian Patent Application No. 2002356763 (hide)

Owner MEDIGENE AKTIENGESELLSCHAFT

Inventors DINKEL, Adelheid; SARTORIUS, Ute; NIELAND, John; BREIDENSTEIN, Claudia

Pub. Number AU-A-2002356763

PCT Number PCT/EP02/13531

PCT Pub. Number WO2003/045428

Priority 60/334,491 30.11.01 US

Filing date 29 November 2002

Wipo publication date 10 June 2003

International Classifications

A61K 039/00 Medicinal preparations containing antigens or antibodies

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61P 035/00 Antineoplastic agents

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/334,491 30.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002356763

19 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002356764-EXPANDABLE TUBES WITH OVERLAPPING END PORTIONS

2002356762-4-ARYLQUINAZOLINES AND USE THEREOF AS NHE-3 INHIBITORS